Janux Therapeutics, Inc. (JANX)

SEC filing

Janux Therapeutics, Inc.

JANX · CIK 1817713

4 · Nov 14, 2025 · Meyer Andrew Hollman sold 3,333 shares at $30.00/share ($99,990); exercised options for 3,333 shares

Meyer Andrew Hollman sold 3,333 shares at $30.00/share ($99,990); exercised options for 3,333 shares

xslF345X05/form4-11142025_081103.xml

xslF345X05/form4-11142025_081103.xmlSEC.gov

Graphics and non-inline formats (not embedded below).